Clinical Trials Related to Non-small Cell Lung Cancer

Related studies linked through entity extraction aliases.

A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR

Status: COMPLETED
Phase: PHASE1

Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer

Status: TERMINATED
Phase: PHASE1

Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Status: COMPLETED
Phase: PHASE2

Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC)

Status: UNKNOWN
Phase: PHASE2

Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer

Status: COMPLETED
Phase: PHASE1

A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone

Status: COMPLETED
Phase: PHASE3

Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer

Status: COMPLETED
Phase: PHASE2

Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer

Status: COMPLETED
Phase: N/A

CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC)

Status: WITHDRAWN
Phase: PHASE2

A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients

Status: COMPLETED
Phase: PHASE1

A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments

Status: COMPLETED
Phase: PHASE2

Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC

Status: COMPLETED
Phase: PHASE2/PHASE3

Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer

Status: TERMINATED
Phase: EARLY_PHASE1

Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.

Status: COMPLETED
Phase: N/A

A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers

Status: COMPLETED
Phase: PHASE1

Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation

Status: COMPLETED
Phase: PHASE1/PHASE2

First Line Gefitinib by FDG-PET Metabolic Response

Status: UNKNOWN
Phase: PHASE2

Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer

Status: COMPLETED
Phase: N/A

Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients

Status: TERMINATED
Phase: N/A

Integrated Molecular Profiling in Advanced Cancers Trial

Status: ACTIVE_NOT_RECRUITING
Phase: N/A